SPHACY is formed by three primary keywords: “Technology – Pharmaceutical – Health”. It is through Technology alone that businesses can achieve swift expansion and accelerated sales.
LOGIN
Mar
On November 21, 2024, Mr. Vu Van Thanh, CEO of SPHACY, had the honor of joining the delegation attending the BRICS 2024 Urban Economic Forum in Saint Petersburg, Russia. This event was not only an opportunity for SPHACY to affirm its position in the medical technology sector but also opened up numerous new prospects for [...]
Mar
1. Announcement Details On February 24, 2025, the Department of Health received Decision No. 92/QĐ-QLD from the Drug Administration of Vietnam (DAV) under the Ministry of Health regarding the revocation of marketing authorization for certain drugs in Vietnam. This measure is essential to ensure public safety and maintain quality control over pharmaceuticals in the market. [...]
Distribution Companies
Production companies
GPP Pharmacies
Provinces – Cities
Users
GDP Agents
Mar
On November 21, 2024, Mr. Vu Van Thanh, CEO of SPHACY, had the honor of joining the delegation attending the BRICS 2024 Urban Economic Forum in Saint Petersburg, Russia. This event was not only an opportunity for SPHACY to affirm its position in the medical technology sector but also opened up numerous new prospects for [...]
Mar
On November 21, 2024, Mr. Vu Van Thanh, CEO of SPHACY, had the honor of joining the delegation attending the BRICS 2024 Urban Economic Forum in Saint Petersburg, Russia. This event was not only an opportunity for SPHACY to affirm its position in the medical technology sector but also opened up numerous new prospects for [...]
Dec
Recently, Vietnam Business Newspaper highlighted SPHACY Joint Stock Company as a prime example of leveraging technology in the pharmaceutical industry, driving innovation and digital transformation in this field. Over the years, Vietnam’s pharmaceutical industry has made significant strides, contributing greatly to the improvement of public health. However, like many other sectors, the pharmaceutical industry faces [...]
LOGIN
En
Vi
